Rickardson L, Kutvonen E, Orasniemi S, Högberg M, Kallio MJ, & Rehnmark S. (2017). Evaluation of the antitumor activity of NOV202, a novel microtubule targeting and vascular disrupting agent. Dove Medical Press.
Chicago Style (17th ed.) CitationRickardson L, Kutvonen E, Orasniemi S, Högberg M, Kallio MJ, and Rehnmark S. Evaluation of the Antitumor Activity of NOV202, a Novel Microtubule Targeting and Vascular Disrupting Agent. Dove Medical Press, 2017.
MLA (9th ed.) CitationRickardson L, et al. Evaluation of the Antitumor Activity of NOV202, a Novel Microtubule Targeting and Vascular Disrupting Agent. Dove Medical Press, 2017.
Warning: These citations may not always be 100% accurate.